Vsevolod N. Galkin,
Doct. Sci. (Medicine), Professor, Chief Physician, City Clinical Oncological Hospital №1, ORCID: https://orcid.org/0000-0002-6619-6179
Author's articles:
PATHWAY DIRECTED MECHANISMS OF ANTI-EGFR RESISTANCE IN COLORECTAL CANCER (REVIEW)
Background: Targeting the epidermal growth factor receptor (EGFR) with cetuximab or panitumumab (anti-EGFR MAb) has been historically reserved ...